Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2014
05/27/2014CA2597255C Natural ligand of g protein coupled receptor rcc356 and uses thereof
05/27/2014CA2564989C Reducing the risk of human and anti-human antibodies through v gene manipulation
05/27/2014CA2562024C Methods for treating bone cancer pain by administering a nerve growth factor antagonist
05/27/2014CA2551696C Immunopotentiator and method of enhancing immunoactivity using the same
05/27/2014CA2508375C Antibodies directed to tumor necrosis factor and uses thereof
05/27/2014CA2481719C Modified cea nucleic acid and expression vectors
05/27/2014CA2406033C Anti-d monoclonal antibodies
05/27/2014CA2343335C Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
05/27/2014CA2310228C Attaching substances to micro-organisms
05/27/2014CA2283143C Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction
05/22/2014WO2014078733A1 Pictet-spengler ligation for protein chemical modification
05/22/2014WO2014078724A1 Treatment of post-traumatic stress disorder using botulinum toxin a
05/22/2014WO2014078688A2 Recombinant adenoviruses and use thereof
05/22/2014WO2014078674A1 Swine influenza hemagglutinin and neuraminidase variants
05/22/2014WO2014078656A1 Gonorrheal mtre peptides and vaccines
05/22/2014WO2014078627A1 Liquid formulations for tnfr:fc fusion proteins
05/22/2014WO2014078622A1 Method and system for diagnosing and treating preeclampsia
05/22/2014WO2014078561A1 Compositions, vectors, kits & methods for immunizing against avian infectious bronchitis virus
05/22/2014WO2014078503A1 Methods of treating ovarian cancer with dll4 antagonists
05/22/2014WO2014078502A1 Use of il-1 beta binding antibodies for treating peripheral arterial disease
05/22/2014WO2014078373A1 Antimicrobial compositions
05/22/2014WO2014077977A1 Recombinant polypeptide construct comprising multiple enterotoxigenic escherichia coli fimbrial subunits
05/22/2014WO2014077825A1 Synthetic peptide-based emergency vaccine against foot and mouth disease (fmd)
05/22/2014WO2014077777A1 Monoclonal antibodies targeting neutralizing epitopes on h7 influenza viruses
05/22/2014WO2014077723A1 Method for obtaining a probiotic preparation of particulate antigens of corynebacteria, probiotic bacterial preparation for preventing and treating tuberculosis, and symbiotic strain
05/22/2014WO2014077648A1 Antibody binding specifically to human and mouse l1cam protein, and use therefor
05/22/2014WO2014077244A1 Transdermal absorption sheet, and manufacturing method for same
05/22/2014WO2014077242A1 Method for manufacturing transdermal-absorption sheet
05/22/2014WO2014077096A1 Method for preventing infections using combination of vector vaccine and live vaccine
05/22/2014WO2014076714A2 Novel immunogenic antigens of shigella
05/22/2014WO2014075631A1 Method for preparing autologous tumor vaccine and use thereof
05/22/2014WO2014075576A1 Humanized anti-human epidemic growth factor receptor antibody and encoding gene and application thereof
05/22/2014WO2014055967A3 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
05/22/2014WO2014015091A3 Bovine influenza c virus compositions
05/22/2014WO2013036791A3 Modified adenoviral vectors and methods of treatment using same
05/22/2014WO2011139974A9 Anti-pai-1 antibodies and methods of use thereof
05/22/2014US20140142151 Allantoin-containing skin cream
05/22/2014US20140141983 Methods of disease activity profiling for personalized therapy management
05/22/2014US20140141492 Cellular Permissivity Factor for Viruses and Uses Thereof
05/22/2014US20140141089 Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
05/22/2014US20140141070 Liposomes having useful n:p ratio for delivery of rna molecules
05/22/2014US20140141046 Method and composition for producing a cellular allogeneic vaccine
05/22/2014US20140141045 Allogeneic Tumor Cell Vaccination
05/22/2014US20140141044 Cord Colitis Syndrome Pathogen
05/22/2014US20140141043 Compositions, vectors, kits, and methods for immunizing against avian infectious bronchitis virus
05/22/2014US20140141040 Avirulent, immunogenic flavivirus chimeras
05/22/2014US20140141039 Biomarker for Monitoring Patients
05/22/2014US20140141036 In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles
05/22/2014US20140141032 TEMPO-mediated glycoconjugation of immunogenic composition against Campylobacter jejuni with improved structural integrity and immunogenicity
05/22/2014US20140141029 Chimeric ospa genes, proteins and methods of use thereof
05/22/2014US20140141020 Anti-cd3 therapies
05/22/2014US20140141017 Methods of diagnosing atherosclerosis by measuring apoci
05/22/2014US20140141013 Anti-il-6 antibodies, compositions, methods and uses
05/22/2014US20140141010 Use of adsl activator to achieve glycemic control in mammals
05/22/2014US20140141006 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
05/22/2014US20140141003 Neutralizing prolactin receptor antibody mat3 and its therapeutic use
05/22/2014US20140141000 Bispecific EGFR/C-Met Antibodies
05/22/2014US20140140997 Methods of Treating Retroviral Infections in Felines
05/22/2014US20140140994 Cell-based assay for assessing tnf alpha inhibitors
05/22/2014US20140140993 Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
05/22/2014US20140140992 Sustained Release Formulations for Delivery of Proteins to the Eye and Methods of Preparing Same
05/22/2014US20140140991 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
05/22/2014US20140140989 Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
05/22/2014US20140140988 Combination therapy of an afucosylated cd20 antibody with a mdm2 inhibitor
05/22/2014US20140140986 Materials and methods for directing an immune response to an epitope
05/22/2014US20140140982 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
05/22/2014US20140140958 Spiro[2.4]heptanes for Treatment of Flaviviridae Infections
05/22/2014US20140140957 Spiro[2.4]heptanes for Treatment of Flaviviridae Infections
05/22/2014US20140140924 Humanized L243 Antibodies
05/21/2014EP2732809A1 Oral composition
05/21/2014EP2732288A1 Biological microchip for the estimation of immunoglobulin e and g levels in human blood, method of assay thereof, and reagent kit comprising same
05/21/2014EP2732034A1 Hbv polymerase mutants
05/21/2014EP2731967A1 Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
05/21/2014EP2731677A1 Antibodies that bind to ox40 and their uses
05/21/2014EP2731625A1 Rspo binding agents and uses thereof
05/21/2014EP2731624A1 Prevention and treatment of pain using antibodies to lysophosphatidic acid
05/21/2014EP2731623A1 Treatment with anti-pcsk9 antibodies
05/21/2014EP2731622A1 Vaccine composition with aluminium hydroxide nanoparticles
05/21/2014EP2731621A1 Parenteral norovirus vaccine formulations
05/21/2014CN103814123A 携带肿瘤抗原的微生物 Microorganism carrying the tumor antigens
05/21/2014CN103813805A Egfr靶向疗法 Egfr targeted therapies
05/21/2014CN103813804A 用于治疗银屑病的方法 Method for the treatment of psoriasis
05/21/2014CN103813803A 2-羟基马尿酸衍生物及其它们的合成方法和用途 2-hydroxy-hippuric acid derivatives and methods for their synthesis and use
05/21/2014CN103813788A 治疗前列腺癌的方法 Treatment of prostate cancer
05/21/2014CN103813786A 用于局部递送的蛋白纳米载体 For topical delivery of a protein nanocarriers
05/21/2014CN103805615A 密码子优化的非洲猪瘟病毒p54基因、其核酸疫苗及应用 Codon optimized African swine fever virus p54 gene, DNA vaccine and its application
05/21/2014CN103805573A 一种重组腺病毒rAd-ORF2-TCE及其应用 One kind of recombinant adenovirus rAd-ORF2-TCE and its application
05/21/2014CN103805572A 预防和治疗水禽h9亚型禽流感的疫苗及其制备方法和应用 Vaccine and its preparation method and application of prevention and treatment of avian influenza subtype waterfowl h9
05/21/2014CN103805532A 一种坏死梭杆菌重组omp蛋白及制备方法 One kind necrosis Fusobacterium recombinant protein and preparation methods omp
05/21/2014CN103804497A 一种抗人Delta like4单克隆抗体 An anti-human monoclonal antibody Delta like4
05/21/2014CN103804496A 一种特异性识别并结合Aβ42寡聚体的单链抗体及单链抗体基因 One kind specifically recognize and bind Aβ42 oligomers single-chain antibody and single-chain antibody gene
05/21/2014CN103804495A 抗肿瘤基因工程二价类抗体及其制备方法及抗肿瘤基因工程药物 Anti-tumor genetic engineering bivalent class antibodies and methods of genetic engineering and anti-tumor drug
05/21/2014CN103800904A Hat乙酰化启动子和其组合物在促进免疫原性中的用途 Hat acetylation promoters and combinations thereof in promoting the use of the immunogenic
05/21/2014CN103800901A 链球菌以及将其灭活得到的奶牛乳房炎疫苗 Streptococcus and bovine mastitis vaccine to inactivated obtained
05/21/2014CN103800900A 金黄色葡萄球菌以及将其灭活得到的奶牛乳房炎疫苗 Staphylococcus aureus mastitis in dairy cows and its inactivated vaccine obtained
05/21/2014CN103800899A 一种奶牛乳房炎疫苗 One kind of cow mastitis vaccine
05/21/2014CN103800898A 一种肿瘤特异性杀伤细胞制剂及其制备方法 A specific killing of tumor cells and its preparation method
05/21/2014CN103800897A 一种肿瘤特异抗原表位多肽负载的树突状细胞疫苗制备方法及其试剂盒 A tumor-specific antigen epitope peptide loaded dendritic cell vaccine preparation method and kit
05/21/2014CN103800896A 一种自体肿瘤疫苗的制备方法及其应用 A preparation of autologous tumor vaccine and its application
05/21/2014CN103800320A 含有炎琥宁及其药学上可接受的盐的药物组合物在制备兽用免疫增强剂方面的用途 Pharmaceutical compositions containing the Yanhuning and pharmaceutically acceptable salts thereof in the manufacture of veterinary aspects of the use of immune enhancer
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 1823